Gopal Singh9060 180Th St, Jamaica, NY 11432

2014032, Oct 30, 2014

Apr 4, 2014

14/245387

- New York NY, US
JOSHUA SONETT - HO HO KUS NJ, US
JOHN O'NEILL - NEW YORK NY, US
MATTHEW BACCHETTA - NEW YORK NY, US
DONALD O. FREYTES - SUMMIT NJ, US
GOPAL SINGH - NEW YORK NY, US
SCOTT A. KANNER - BROOKLYN NY, US

The Trustees of Columbia University in the City of New York - New York NY

A01N 1/02

435 12, 4352841

The vasculature of a donor lung is perfused with a lung preserving fluid to preserve its structure. At the same time, a decellularization fluid is perfused through the airways, which strips away donor cells. The decellularized region is then seeded with pulmonary cells of the transplant recipient, which regenerate the lung. The pulmonary cells may be derived from stem cells, and the decellularization can be targeted to reduce the quantity of cells required.

2014022, Aug 7, 2014

Apr 11, 2014

14/250828

- New York NY, US
Gopal Singh - Oakland Gardens NY, US
Maurizio A. Miglietta - New York NY, US

The Trustees of Columbia University in the City of New York - New York NY

A61L 15/28
A61L 15/32
A61L 15/38
A61L 15/18

424445, 424 9464, 424447

A wound treatment system having a formulation to retard bleeding. In particular, the wound treatment system includes medical device, e.g. bandage, which can be adapted for internal or external use. The wound treatment system includes a fabric substrate having a formulation, wherein the formulation includes chitosan, kaolin, fibrinogen, and thrombin.